Cryoport, Inc. (CYRX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Cryoport reported revenue of $176.2M, down 22.9% from $228.4M the year before. Net income was $78.3M (a 44.4% net margin), or $1.40 per diluted share. Gross margin was 47.1% and operating margin was -20.9%. Operating activities generated -$8.6M of cash, leaving -$25.0M of free cash flow. At fiscal year end, Cryoport held $765.0M in total assets against $262.4M in total liabilities, including $250.5M of cash and equivalents.
Open the full interactive Cryoport financials → Quarterly statements, key ratios, valuation history and price charts.
Cryoport Key Stats
| Share Price | $16.95 |
|---|---|
| Market Cap | $855.0M |
| P/E Ratio | 12.1 |
| Revenue YoY Growth | -22.9% |
| 52-Week Range | $7.72 – $18.14 |
| Shares Outstanding | 50.4 million (basic, 2026 Q2) |
Cryoport Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $78.7M | $222.6M | $237.3M | $233.3M | $228.4M | $176.2M |
| Gross Profit | $36.3M | $96.6M | $103.9M | $99.3M | $99.6M | $83.1M |
| Operating Income | -$30.0M | -$17.8M | -$31.9M | -$115.2M | -$130.9M | -$36.8M |
| Pre-Tax Income | -$32.7M | -$273.8M | -$35.1M | -$99.3M | -$113.5M | -$32.2M |
| Income Tax | -$45,000 | $1.7M | $2.2M | $239,000 | $1.3M | $1.8M |
| Net Income | -$32.7M | -$275.5M | -$37.3M | -$99.6M | -$114.8M | $78.3M |
| Diluted EPS | -$1.94 | -$6.19 | -$0.93 | -$2.21 | -$2.49 | $1.40 |
Cryoport Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $44.2M | $45.5M | $47.8M | $49.0M |
| Net Income | -$6.9M | -$8.0M | -$10.5M | -$8.3M |
| Diluted EPS | -$0.18 | -$0.16 | -$0.25 | -$0.20 |
Cryoport Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $36.9M | $139.1M | $36.6M | $46.3M | $45.3M | $250.5M |
| Current Assets | $147.2M | $693.5M | $604.2M | $535.1M | $341.6M | $476.2M |
| Total Assets | $552.4M | $1.11B | $1.04B | $957.7M | $703.5M | $765.0M |
| Current Liabilities | $35.0M | $42.6M | $40.9M | $45.6M | $64.6M | $219.0M |
| Total Long-Term Debt | $116.3M | $405.3M | $407.1M | $380.0M | $199.5M | $186.3M |
| Total Liabilities | $169.7M | $471.1M | $482.9M | $468.7M | $301.6M | $262.4M |
| Shareholders' Equity | $382.7M | $641.8M | $555.8M | $489.0M | $401.9M | $502.6M |
Cryoport Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$14.9M | $8.1M | -$1.9M | -$757,000 | -$16.3M | -$8.6M |
| Cash From Investing | -$382.3M | -$469.3M | -$59.7M | $36.0M | $176.8M | $250.3M |
| Cash From Financing | $385.6M | $564.3M | -$39.2M | -$23.8M | -$161.5M | -$21.1M |
| Free Cash Flow | -$23.8M | -$15.8M | -$24.0M | -$39.5M | -$33.6M | -$25.0M |
Figures from Cryoport's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cryoport financials page for every line item.
Cryoport Company Profile
| Ticker | CYRX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Brentwood, Tennessee |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001124524 |
Frequently Asked Questions
What was Cryoport's revenue in fiscal 2025?
Cryoport (CYRX) reported revenue of $176.2M for fiscal 2025.
What is Cryoport's annual revenue history?
Cryoport's annual revenue by fiscal year: 2020: $78.7M; 2021: $222.6M; 2022: $237.3M; 2023: $233.3M; 2024: $228.4M; 2025: $176.2M.
What was Cryoport's net income in fiscal 2025?
Cryoport reported net income of $78.3M for fiscal 2025.
What was Cryoport's earnings per share (EPS) in fiscal 2025?
Cryoport's diluted EPS was $1.40 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cryoport generate in fiscal 2025?
Cryoport generated -$25.0M of free cash flow in fiscal 2025.
What was Cryoport's revenue last quarter?
In its most recent reported quarter (2026 Q2), Cryoport reported revenue of $49.0M.
How much debt does Cryoport have?
Cryoport reported $186.3M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Cryoport are outstanding?
Cryoport reported a weighted average of 50.4 million basic shares outstanding in 2026 Q2.
What is Cryoport's market cap?
Based on its latest closing price, Cryoport (CYRX) has a market capitalization of about $855.0M.
When does Cryoport's fiscal year end?
Cryoport's fiscal year end, as registered with the SEC, is December 31.
Where is Cryoport headquartered?
Cryoport lists its business address in Brentwood, Tennessee in its SEC filings.